SCHEMBL19903687

SCHEMBL19903687

N#Cc1cc(-n2c3ccccc3c3cc(C(F)(F)F)ccc32)c(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)c(-n2c3ccccc3c3cc(C(F)(F)F)ccc32)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 3/20 0.39
RXRA P19793 1/20 0.36
RXRG P48443 1/20 0.36
TAS2R14 Q9NYV8 1/20 0.34
MAT2A P31153 1/20 0.33
HSP90AA1 P07900 1/20 0.33
XDH P47989 1/20 0.32
RORC P51449 3/20 0.32
TACR1 P25103 1/20 0.32
CYP1A2 P05177 1/20 0.32
METAP2 P50579 1/20 0.32
PGR P06401 1/20 0.32
NR1H3 Q13133 1/20 0.32
CTSS P25774 1/20 0.32
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
PPARG P37231 1/20 0.31
PPARA Q07869 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2B Q13224 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22564387 0.98 KIF11 (0.39) KIF11RXRARXRGTAS2R14MAT2A
SCHEMBL19903636 0.94 KIF11 (0.37) KIF11RXRARXRGTAS2R14MAT2A
SCHEMBL21414102 0.94 KIF11 (0.40) KIF11RXRARXRGTAS2R14MAT2A
SCHEMBL24002968 0.94 RXRA (0.39) KIF11RXRARXRGTAS2R14XDH
SCHEMBL19918026 0.94 KIF11 (0.40) KIF11RXRARXRGTAS2R14MAT2A
SCHEMBL19903540 0.93 RXRA (0.36) KIF11RXRARXRGTAS2R14MAT2A
SCHEMBL19903689 0.93 KIF11 (0.45) KIF11RXRARXRGTAS2R14MAT2A
SCHEMBL22564465 0.92 KIF11 (0.37) KIF11RXRARXRGTAS2R14MAT2A
SCHEMBL19903528 0.92 RXRA (0.40) KIF11RXRARXRGTAS2R14XDH
SCHEMBL22564397 0.92 RXRA (0.41) KIF11RXRARXRGTAS2R14MAT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-10-08 US disclosed
EP-3287450-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-03-20 EP disclosed
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287450-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, ORC3, AOC3 KIF11 3253/4885RXRA 3779/4885RXRG 3669/4885
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 KIF11 3316/4885RXRA 3635/4885RXRG 3474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.